CytomX Therapeutics, Inc. (CTMX)

NASDAQ: CTMX · IEX Real-Time Price · USD
1.66
+0.01 (0.61%)
At close: Aug 19, 2022 4:00 PM
1.64
-0.02 (-1.20%)
After-hours: Aug 19, 2022 4:06 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 202120202019201820172016201520142013
Revenue
69.57100.3657.4959.571.6215.047.715.080.89
Revenue Growth (YoY)
-30.68%74.58%-3.38%-16.92%376.12%95.06%51.90%471.73%-
Gross Profit
69.57100.3657.4959.571.6215.047.715.080.89
Selling, General & Admin
39.1636.0336.7733.5125.6119.8712.566.544.95
Research & Development
114.19112.94131.62103.8792.2854.7628.3628.310.89
Operating Expenses
153.35148.97168.38137.38117.8874.6340.9234.8415.84
Operating Income
-83.78-48.61-110.9-77.87-46.26-59.59-33.2-29.77-14.96
Interest Expense / Income
0000001.730.490.25
Other Expense / Income
-0.17-1.81-8.23-7.57-2.65-0.670.430.05-0.08
Pretax Income
-83.61-46.8-102.67-70.3-43.61-58.92-35.36-30.3-15.13
Income Tax
0-13.91-0.4314.3-0.51-0.020.010.010.01
Net Income
-83.61-32.89-102.24-84.6-43.1-58.9-35.37-30.31-15.14
Preferred Dividends
0000006.714.573.75
Net Income Common
-83.61-32.89-102.24-84.6-43.1-58.9-42.08-34.88-18.89
Shares Outstanding (Basic)
644645423736911
Shares Outstanding (Diluted)
644645423736911
Shares Change
39.01%1.79%8.81%12.10%2.57%321.57%768.69%28.11%-
EPS (Basic)
-1.30-0.71-2.26-2.03-1.16-1.63-4.90-35.25-24.46
EPS (Diluted)
-1.30-0.71-2.26-2.03-1.16-1.63-4.90-35.25-24.46
Free Cash Flow Per Share
-1.880.06-3.18-1.904.54-0.12-3.3830.46-11.32
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-120.40%-48.40%-192.90%-130.90%-64.60%-396.10%-430.50%-586.30%-1684.20%
Profit Margin
-120.20%-32.80%-177.80%-142.20%-60.20%-391.50%-545.60%-686.90%-2127.70%
Free Cash Flow Margin
-173.40%2.90%-250.40%-133.30%235.70%-27.60%-376.20%593.60%-984.20%
Effective Tax Rate
0.00%29.73%0.42%-20.35%1.18%0.03%-0.03%-0.03%-0.07%
EBITDA
-77.77-41.34-97.39-68.42-41.95-57.19-32.43-29.03-14.22
EBITDA Margin
-111.80%-41.20%-169.40%-115.00%-58.60%-380.20%-420.50%-571.80%-1601.80%
Depreciation & Amortization
5.845.465.281.881.661.731.210.780.66
EBIT
-83.61-46.8-102.67-70.3-43.61-58.92-33.63-29.81-14.88
EBIT Margin
-120.20%-46.60%-178.60%-118.10%-60.90%-391.70%-436.10%-587.20%-1675.60%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).